Pulmonary complications in intravenous drug users with and without human immunodeficiency virus co-infection
Conclusion: pulmonary complications and secondary manifestations of HIV predominate in the clinic in HIV-infected IDUs. The current is characterized by an unfavorable prognosis. Appropriate antimicrobial therapy, control of the infectious source and resolution of the illness can be expected for most patients- IDUs with early diagnosis of pulmonary complications in the absence of HIV.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Klester, K., Klester, E., Shoikhet, Y., Zharikov, A. Tags: Respiratory infections Source Type: research
More News: Antibiotic Therapy | Candida | Hepatitis | Hepatitis B | Infectious Diseases | MRSA | Pain | Pneumonia | Respiratory Medicine | Staphylococcus Aureus | Study | Superbugs | Tuberculosis